Abeome Corp.

Preclinical stage antibody discovery company with a transgenic mouse platform

placeAthens, Georgia, United States calendar_todayFounded 2006 language abeomecorp.com

Innovation

4 patent families (2 granted) — focus: Chemistry & metallurgy; filing pace slowing. Cited 382 times.

YearFilings
20121
20131
20141
20161
20171
20181
20192
20202
20211
20222
20231
20242

Investor mix

4 investors on record.

Investor typeCountShare
Venture capital125%
Other / undisclosed375%
Coming soon